The drug "Furamag". Instructions for use

The drug "Furamag" is a medicinal product, the action of which is aimed at creating an antimicrobial effect. The drug belongs to the group of nitrofurans.

The drug "Furamag", the instruction for which is available in the package, is issued by the pharmacological industry in the form of hard capsules having a gelatinous shell of yellow-brown color. Inside is the powder. The color of the contents of the capsule varies from orange to reddish and has a brown tinge. Standards allow the interspersing of yellow, white, orange-brown or orange particles.

The main active component of the drug is furazilin, which has the form of potassium salt. Auxiliary elements are talc and potassium carbonate, as well as magnesium hydroxycarbonate. Components of the capsule are gelatin and yellow iron oxide, which is a dye, as well as titanium dioxide and gelatin. The preparation is packed into 10 blisters.

The drug "Furamag", the instruction for its use describes in detail the main pharmacological properties of the drug, refers to antimicrobial agents. Its area of influence is Gram-positive cocci and protozoa, which show resistance to antibiotics. When the vital activity of most of the pathogenic bacteria is suppressed, the action of the drug is aimed at interrupting the chain of respiration and the cycle of tricarboxylic acids. Also, the medicine destroys the cytoplasmic membrane and the envelope of harmful flora, which causes its death.

Microorganisms exposed to the drug "Furamag" reduce the release of toxic substances. This helps to improve the state of the patient's organism until the growth of pathogenic microflora ceases. Nitrofurans are able to increase immunity and activate the action of leukocytes, aimed at phagocytosis of microorganisms. The main component of the drug - furazilin - promotes the stimulation of leukopoiesis in the appointment of a therapeutic dosage.

The drug "Furamag", the instruction on its application explains the principle of its effect, is able to be absorbed in the small intestine. This process passes on the principle of passive diffusion. Absorption into the bloodstream of furazilin is most effective from the small intestine.

Great availability is available for oral use. The distribution of furazilin in the body is made evenly. When carrying out a course of treatment, a high concentration of the active substance in the lymph is of particular importance, where the drug inhibits the growth and spread of the infection through the lymphatic channels.

The drug "Furamag", the instruction for its use acquaints us with the field of its use, is prescribed for the development of infectious processes caused by microorganisms sensitive to it.

The drug finds application in the occurrence of various types of pathologies. These include infections of the skin and soft tissue, as well as gynecological and urogenital. Recommended intake of the drug and for preventive purposes in preparation for operations of a urological nature. It is used in the complex treatment of infected burns, classified as severe.

The medication is taken orally after a meal. Use of the drug "Furamag" for children is possible only from the age of three.

Possible unwanted side effects during the course of treatment: vomiting and nausea, as well as a decrease in appetite and impaired liver function. Sometimes there are headaches and dizziness, as well as polyneuritis and rashes on the skin.

The drug "Furamag" is not prescribed during pregnancy, as well as during lactation and with individual hypersensitivity to its components.